Intensive Outpatient Treatment of Pediatric Rumination Syndrome in the Era of Telemedicine.
Journal
Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545
Informations de publication
Date de publication:
01 03 2023
01 03 2023
Historique:
pubmed:
29
7
2022
medline:
3
3
2023
entrez:
28
7
2022
Statut:
ppublish
Résumé
We have had success treating children with severe rumination syndrome using a multidisciplinary intensive outpatient program (IOP) involving multiple treatment sessions daily. During the coronavirus disease 2019 (COVID-19) pandemic, we temporarily transitioned care to telemedicine. The objective of this study is to compare outcomes of patients with rumination syndrome who completed IOP treatment in person versus by telemedicine. We performed a retrospective review of patients diagnosed with rumination syndrome who participated in IOP treatment from 2018 to 2020. Similar treatment sessions were performed involving medical and behavioral techniques provided by a multidisciplinary team during telemedicine visits. Families/patients were asked to complete a survey outlining their child's current rumination symptom severity and review the IOP. We included 34 patients (79% F, median age 15 years, range 7-19 years) who completed IOP treatment. Twenty-six patients (76%) were treated in person and 8 patients (24%) by telemedicine. For patients treated in person, 76% (19/25) had improvement in symptoms while 16% (4/25) had complete resolution of symptoms. For patients treated by telemedicine, 88% (7/8) had improvement in their symptoms. There were no significant differences between groups in likelihood of improvement. Overall, 78% (18/23) preferred in person therapy while 17% (4/23) did not have a preference. All 18 of the in-person cohort who completed follow-up surveys preferred in-person management. Multidisciplinary intensive outpatient treatment for children and adolescents with severe rumination syndrome is effective. Although telemedicine may be an alternative to in person therapy, majority of families prefer in person visits.
Identifiants
pubmed: 35897133
doi: 10.1097/MPG.0000000000003577
pii: 00005176-202303000-00004
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
278-281Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Hyams J, Carlo D, Miguel S, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 2016;150:1456–68.
Mousa HM, Montgomery M, Alioto A. Adolescent rumination syndrome. Curr Gastroeneterol Rep 2014;16:398.
Alioto A, Di Lorenzo C, Montgomery ML, et al. High cost and low yield: the diagnostic evaluation of rumination syndrome in pediatrics. J Pediatr 2017;185:155–9.
Alioto A, DiLorenzo C. Long-term follow-up o f adolescents treated for rumination syndrome in an inpatient setting. J Pediatr Gastroenterol Nutr 2018;66:21–5.
Barba E, Burri E, Accarino A, et al. Biofeedback-guided control of abdominothoracic muscular activity reduces regurgitation episodes in patients with rumination. Clin Gasroenterol Hepatol 2015;13:100–6.
Chial HJ, Camilleri M, Williams E, et al. Rumination syndrome in children and adolescents: diagnosis, treatment, and prognosis. Pediatrics 2003;111:158–62.
Rosen R, Rodriguez L, Nurko S. Pediatric rumination subtypes: a study using high-resolution esophageal manometry with impedance. Neurogastroenterol Motil 2016;29:1–9.
Green AD, Alioto A, Mousa H, et al. Severe pediatric rumination syndrome: successful interdisciplinary inpatient management. J Pediatr Gastroenterol Nutr 2011;52:414–8.
Wosik J, Fudim M, Cameron B, et al. Telehealth transformation: COVID-19 and the rise of virtual health care. J Am Med Inform Assoc 2020;27:957–62.
Lee JA, Di Tosto G, McAlearney FA, et al. Physician perspectives about telemedicine: considering the usability of telemedicine in response to coronavirus disease 2019. J Pediatr Gastroenterol Nutr 2021;73:42–7.
Cross RK, Langenberg P, Regueiro M, et al. A randomized controlled trial of TELEmedicine for patients with inflammatory bowel disease (TELE-IBD). Am J Gastroenterol 2019;114:472–82.
Elkjaer M, Shuhaibar M, Burisch J, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘Constant-care’ approach. Gut 2010;59:1652–61.
Kennedy AP, Nelson E, Reeves D, et al. A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Gut 2004;53:1639–45.
Richardson G, Sculpher M, Kennedy A, et al. Is self-care a cost-effective use of resources? Evidence from a randomized trial in inflammatory bowel disease. J Health Serv Res Policy 2006;11:225–30.
Robinson A, Thompson DG, Wilkin D, et al. Northwest Gastrointestinal Research Group. Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial. Lancet 2001;358:976–81.
Williams JG, Cheung WY, Russell IT, et al. Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study. BMJ 2000;320:544–8.
Cross RK, Kane S. Integration of telemedicine into clinical gastroenterology and hepatology practice. Clin Gastroenterol Hepatol 2017;15:175–81.
Cross RK, Cheevers N, Rustgi A, et al. Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT). Inflamm Bowel Dis 2012;18:1018–25.
Nguyen M, Waller M, Pandya A, et al. A review of patient and provider satisfaction with telemedicine. Curr Allergy Asthma Rep 2020;20:1–7.